Market Cap | 77.15M | P/E | 82.15 | EPS this Y | - | Ern Qtrly Grth | - |
Income | 1.64M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 1.00% |
Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | 3.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -8.00% |
Recommedations | - | Quick Ratio | 0.20 | Shares Outstanding | 2.91M | 52W Low Chg | 7.00% |
Insider Own | 31.43% | ROA | - | Shares Float | 2M | Beta | - |
Inst Own | 65.86% | ROE | - | Shares Shorted/Prior | 154/523 | Price | 10.68 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 2,167 | Target Price | - |
Oper. Margin | - | Earnings Date | - | Volume | 1 | Change | 0.00% |
ALSP Orchid Acquisition Corporation I does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to target life science companies in North America and Singapore. ALSP Orchid Acquisition Corporation I was incorporated in 2021 and is based in Seattle, Washington.
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Le Thong Q. | Chief Executive Offi.. Chief Executive Officer | Nov 22 | Buy | 10 | 915,000 | 9,150,000 | 915,000 | 03/18/22 |